Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results.
about
Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor functionEGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabMechanisms underlying skin disorders induced by EGFR inhibitorsToxin-based targeted therapy for malignant brain tumorsCombination treatment including targeted therapy for advanced hepatocellular carcinomaChlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal originCorrelation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma.Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activationDown-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instability.Activation of epidermal growth factor receptor is required for NTHi-induced NF-κB-dependent inflammation.Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors.ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.Polymer carriers for anticancer drugs targeted to EGF receptor.IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.New trends in epidermal growth factor receptor-directed monoclonal antibodies.The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cellsPotential roles of Centipede Scolopendra extracts as a strategy against EGFR-dependent cancers.Advances on EGFR mutation for lung cancer.Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular CarcinomaEmerging drugs for non-small cell lung cancer.Monoclonal antibody therapeutics and apoptosis.Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell Growth via Inhibition of the ERK-Dependent EGF Receptor Signaling Pathway.Molecularly-targeted therapies for non-small cell lung cancer.Relationship between Preoperative ¹⁸F-Fluorodeoxyglucose Uptake and Epidermal Growth Factor Receptor Status in Primary Colorectal Cancer.A Whole-Body Physiologically Based Pharmacokinetic Model of Gefitinib in Mice and Scale-Up to HumansMolecular biology of epidermal growth factor receptor inhibition for cancer therapy.Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancer.Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.Imaging characteristics of stage I non-small cell lung cancer on CT and FDG-PET: relationship with epidermal growth factor receptor protein expression status and survival.Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC).Epidermal growth factor receptor-targeted radioimmunotherapy of human head and neck cancer xenografts using 90Y-labeled fully human antibody panitumumab.Emerging therapies for colorectal cancer.Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).The emerging role of cetuximab in head and neck cancer: a 2007 perspective.Implications of EGFR PharmDx kit for cetuximab eligibility.Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapyNovel targeted therapies in adrenocortical carcinoma.Anti-epidermal growth factor receptor strategies for advanced breast cancer.
P2860
Q24293413-FADE48DD-1257-4C51-9C34-2F3A37EC0B82Q24652337-53E21653-E946-4DA3-B037-6BC83CB2335BQ26745689-8E87DD4E-8558-455B-9905-C17D0B7FA61DQ27006226-37626480-55E7-4B92-B451-60C6DE4C02ABQ28077738-64ADC5DD-A2E5-412A-BFD7-0D47A05A757BQ28214310-2024941C-A564-4E40-B85F-2B8888C5FC06Q33560977-C99B7D94-8009-42B2-BC4F-C3957EDDADD4Q33901255-296F0C78-D9D6-4CE6-9EE2-324CBA6CC1B2Q33912974-4EC2D2D7-9357-4AED-BC46-D326091C72DDQ34088202-D3333ADE-1D6D-4EE9-A816-8460437A71A2Q34194849-D199145B-C12B-4963-8FD6-6712A0BA2732Q34336217-49C5E168-652A-4C6B-A407-544715ED0903Q34364547-DD36FD80-9721-4BBE-A25E-FCCC3F5651BAQ34450114-B5A1D045-AFCC-4986-98CC-C6BCB8A0E632Q34451934-E8B3E4B3-68B5-47E0-BA71-7CAF11B104FBQ34621577-B9B4DF07-436E-4B03-9D0E-29A936E67BC7Q34902490-F1E5CA43-05FB-4302-BC97-8045791B6121Q35137787-A2B3F79A-8E47-41BB-A626-EA5F6AA17814Q35200375-4CDA1EB9-5E22-4E13-93C5-F2B68517E34DQ35445125-40B19B91-5766-4174-AD16-2654E1721421Q35581167-969C31A9-516A-4129-8392-DFC1C45F99E2Q35603396-72C2DC3E-CAD3-4CF8-8A38-D886E0B543BBQ36146089-74FE1F14-7A7F-4E2C-BA4D-54573E3A62FAQ36326239-4C907AAA-C33E-405B-953B-1AF77D6A62B3Q36418722-4FA8A584-9D72-4095-AB63-C793B90D1670Q36445112-904A3200-A484-4EBF-8936-0EB40079ECDCQ36481002-3CE08D81-E279-4D47-8F1A-42D70C411A1BQ36563251-FD932954-5D81-4FB4-B214-86868526A313Q36623214-54305C91-527C-4540-9E57-443204C042CFQ36641553-647A6D87-B99A-4051-A992-ACEC69714F01Q36662662-C54475D2-78D5-4B2D-A66D-0F9AE23DCA39Q36673684-D850A263-0160-4670-9F30-44C061C7CDC0Q36777329-661C45AF-082C-41AE-94F6-DCF9833EFF16Q36821373-EBA54806-DFBC-45F8-BC7D-BF850090776DQ37052752-C738A46D-00FC-4309-959C-B9571B0B3405Q37052756-C857BFD4-28DB-490C-B5C5-764C8CFD9D8CQ37118974-48DEE5A5-57EF-426B-951D-62687F0D27ABQ37154421-85B1F403-9728-4AD8-B8DB-50E65D03B76FQ37233378-010EADBB-ACC3-4FA1-8467-F99B08866058Q37293327-838F9C38-6C0C-4E76-965A-A410B0564B50
P2860
Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epidermal growth factor recept ...... preliminary clinical results.
@ast
Epidermal growth factor recept ...... preliminary clinical results.
@en
type
label
Epidermal growth factor recept ...... preliminary clinical results.
@ast
Epidermal growth factor recept ...... preliminary clinical results.
@en
prefLabel
Epidermal growth factor recept ...... preliminary clinical results.
@ast
Epidermal growth factor recept ...... preliminary clinical results.
@en
P356
P1476
Epidermal growth factor recept ...... preliminary clinical results.
@en
P2093
P2888
P304
P356
10.1023/A:1006384521198
P577
1999-01-01T00:00:00Z
P6179
1030872584